By Ben LevisohnSunTrust Robinson Humphrey’s Edward Nash and team offer five biotech stocks for the next six months:
Cempra (CEMP) ($50 PT), our top pick based on near-term clinical and commercial success potential. We recently met with management and it was reiterated that the second Phase III study of solithromycin in CABP (SOLITAIRE-IV) remains on track to report top-line data by […]
By Ben LevisohnSunTrust Robinson Humphrey’s Edward Nash and team offer five biotech stocks for the next six months:
Cempra (CEMP) ($50 PT), our top pick based on near-term clinical and commercial success potential. We recently met with management and it was reiterated that the second Phase III study of solithromycin in CABP (SOLITAIRE-IV) remains on track to report top-line data by […]
“That’s a high-profile move. That could make people concerned,” said Steve Massocca of Wedbush Securities. “It’s not exactly the cheapest group around. It’s got an elevated valuation here. It does nothing but go up. It doesn’t take much to create a wobble.””It doesn’t appear to be hurting other speculative areas. The social media index is up three-quarters of a percent,” […]
NEW YORK (MarketWatch) — The current bull market is marking its sixth birthday, and a few slices of the stock market have more reason to celebrate than others.Who really deserves to whoop it up? Biotech and pharma ETFs, value ETFs that aim to find bargains, and ETFs targeting consumer-discretionary or retail stocks.The 10 ETFs that have performed best since the […]
NEW YORK (AP) — A surge in oil and gas companies pulled the stock market out of a five-day slump on Friday, as the price of crude swung higher.Oil prices jumped after the International Energy Agency predicted drillers would cut production this year. Exxon Mobil, Chevron and other energy companies led all 10 sectors of the Standard & Poor’s 500 […]
In other news, a Food and Drug Administration advisory panel will meet Wednesday to decide whether to recommend approval for a biosimilar drug, which represents a potentially cheaper alternative to Amgen Inc. ’s Neupogen. If it gains agency approval, this drug would be the first biosimilar to get the FDA’s OK and it could mark the beginning of a new […]
Markets finished a choppy session in the negative territory on Monday as yet another slide in oil prices dented investor sentiment. Moreover, mixed economic data on the domestic front weighed on the benchmarks. The Dow had gained more than 100 points in the initial session, but lost all the gains by the closing bell.For a look at the issues currently […]
Ag Economy; Farm Bill; Budget; Immigration; Trade; Biotech; and, RegulationsCategories: Agricultural Economy /Budget /Farm Bill /Immigration /RegulationsAgricultural EconomyA news release yesterday from USDA’s National Agricultural Statistics Service (NASS) indicated that, “According to the November Crop Production report released today by [NASS], corn production is expected to reach 14.4 billion bushels this year, up 3 percent from 2013 [related graph]. Soybean production is […]
Ukrainians in Czech Republic called up to serve in…12 Aug 2014 10:00 – Czech News AgencyAn estimated 20,000 men living in the country have been drafted by the Ukrainian military to fight t [ … ]Half of Czechs say they fear war may hit country11 Aug 2014 09:00 – Czech News AgencyConflict in Ukraine has people on edge; more than […]
Pinterest is no National Security Agency, but the social network has grown into a collector of plenty information. Like Twitter, Facebook, Google, and other web giants, Pinterest has developed sophisticated systems for storing the data, but it’s also built a tool that lets lots of employees get at it.In a blog today, Pinterest data engineer Mohammad Shahangian sheds light on […]
